Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Doximity Sees Q3 Sales $180.000M-$181.000M vs $180.671M Est

Author: Benzinga Newsdesk | November 06, 2025 04:03pm

Doximity (NYSE:DOCS) sees Q3 sales of $180.000 million-$181.000 million vs $180.671 million analyst estimate.

Posted In: DOCS